Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PharmaRelations AB
AB
Active
Org 5565447983
Frösundaviks Allé 1, 169 70
Solna
Business and other management consultancy activities
·
NACE 7020
Est. 1997 · 28 years old
136 employees
Monitor
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
PharmaRelations AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
313M
234M
156M
78M
0M
2020: 113M
113M
2020
2021: 149M (+32% vs 2020)
149M
+32%
2021
2022: 223M (+50% vs 2021)
223M
+50%
2022
2023: 251M (+13% vs 2022)
251M
+13%
2023
2024: 227M (-10% vs 2023)
227M
-10%
2024
EBITDA
SEK millions
24M
18M
12M
6M
0M
2020: 13M
13M
2020
2021: 14M (+8% vs 2020)
14M
+8%
2021
2022: 19M (+36% vs 2021)
19M
+36%
2022
2023: 19M (0% vs 2022)
19M
0%
2023
2024: 10M (-47% vs 2023)
10M
-47%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
226 647
251 081
223 109
148 633
113 015
Staff expenses
—
—
—
—
—
EBITDA
10 132
19 025
18 984
13 690
12 638
Depreciation & amort.
−73
−73
−103
−103
−49
EBIT
10 059
18 952
18 881
13 587
12 589
Net financials
769
363
−321
−104
−313
Profit before tax
8 878
15 275
15 515
10 513
12 214
Tax
−2 053
−3 306
−3 425
−2 253
−2 721
Net profit
6 825
11 969
12 090
8 260
9 493
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
91 459
93 445
72 783
54 861
39 542
Equity
46 180
39 356
27 387
15 065
16 805
Long-term debt
86
86
4 587
6 082
82
Short-term debt
24 293
35 303
26 410
22 574
14 515
Total debt
24 379
35 389
30 997
28 656
14 597
Financial ratios
5-year trend
EBITDA margin
4,5 %
This company
15,8 %
Market median
This company
Market median
72% below market
2020
2024
Equity ratio
50,5 %
This company
38,2 %
Market median
This company
Market median
32% above market
2020
2024
Return on equity
14,8 %
This company
18,4 %
Market median
This company
Market median
20% below market
2020
2024
Net profit margin
3,0 %
This company
8,1 %
Market median
This company
Market median
63% below market
2020
2024
Asset turnover
2,48×
This company
1,12×
Market median
This company
Market median
121% above market
2020
2024
Debt / equity
0,98×
This company
0,62×
Market median
This company
Market median
58% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on PharmaRelations AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
